Virios Therapeutics, Inc. (NASDAQ:VIRI – Get Free Report)’s stock price shot up 0.6% during trading on Wednesday . The stock traded as high as $1.5902 and last traded at $1.55. Approximately 95,904 shares were traded during trading, a decline of 91% from the average daily volume of 1,049,645 shares. The stock had previously closed at $1.54.
Virios Therapeutics Trading Up 0.6%
The firm has a market cap of $29.85 million, a P/E ratio of -5.74 and a beta of 1.58. The stock’s fifty day moving average is $1.62 and its two-hundred day moving average is $2.81.
About Virios Therapeutics
Virios Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for fibrotic diseases. The company leverages its proprietary small-molecule platform to identify and advance compounds designed to modulate key pathways involved in scar formation and tissue repair. By concentrating on conditions with high unmet medical need, Virios aims to improve patient outcomes through more effective and safer treatment options.
The company’s lead development candidate, VTI-1002, is an oral small molecule inhibitor in clinical trials for the prevention and treatment of hypertrophic scars and keloids.
Featured Articles
- Five stocks we like better than Virios Therapeutics
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for Virios Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virios Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
